These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 7945494)
1. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Denburg SD; Carbotte RM; Denburg JA Arthritis Rheum; 1994 Sep; 37(9):1311-20. PubMed ID: 7945494 [TBL] [Abstract][Full Text] [Related]
2. Treatment pathways in an inception lupus cohort over the first three years. Hanly JG; Sayani A; Doucette S; Iczkovitz S; Terres JAR Lupus; 2017 Feb; 26(2):119-124. PubMed ID: 27365369 [TBL] [Abstract][Full Text] [Related]
3. The effects of corticosteroids on cognitive flexibility and decision-making in women with lupus. Montero-López E; Santos-Ruiz A; Navarrete-Navarrete N; Ortego-Centeno N; Pérez-García M; Peralta-Ramírez MI Lupus; 2016 Nov; 25(13):1470-1478. PubMed ID: 27055522 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of cognitive impairment in systemic lupus erythematosus. Carbotte RM; Denburg SD; Denburg JA J Nerv Ment Dis; 1986 Jun; 174(6):357-64. PubMed ID: 3711879 [TBL] [Abstract][Full Text] [Related]
5. Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids. Ng X; dosReis S; Beardsley R; Magder L; Mullins CD; Petri M Lupus; 2018 Mar; 27(3):475-483. PubMed ID: 28857718 [TBL] [Abstract][Full Text] [Related]
6. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE. Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478 [TBL] [Abstract][Full Text] [Related]
7. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations. Tincani A; Brey R; Balestrieri G; Vitali C; Doria A; Galeazzi M; Meroni PL; Migliorini P; Neri R; Tavoni A; Bombardieri S Clin Exp Rheumatol; 1996; 14 Suppl 16():S23-9. PubMed ID: 9049450 [TBL] [Abstract][Full Text] [Related]
8. The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial. Tseng CE; Buyon JP; Kim M; Belmont HM; Mackay M; Diamond B; Marder G; Rosenthal P; Haines K; Ilie V; Abramson SB Arthritis Rheum; 2006 Nov; 54(11):3623-32. PubMed ID: 17075807 [TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus. Nishimura K; Harigai M; Omori M; Sato E; Hara M Psychoneuroendocrinology; 2008 Apr; 33(3):395-403. PubMed ID: 18261856 [TBL] [Abstract][Full Text] [Related]
11. Weight loss and improvements in fatigue in systemic lupus erythematosus: a controlled trial of a low glycaemic index diet versus a calorie restricted diet in patients treated with corticosteroids. Davies RJ; Lomer MC; Yeo SI; Avloniti K; Sangle SR; D'Cruz DP Lupus; 2012 May; 21(6):649-55. PubMed ID: 22311939 [TBL] [Abstract][Full Text] [Related]
12. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. Carneiro JR; Sato EI J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042 [TBL] [Abstract][Full Text] [Related]
13. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Kozora E; Ellison MC; West S Arthritis Rheum; 2006 Aug; 55(4):628-35. PubMed ID: 16874786 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of antimalarials in systemic lupus erythematosus. Rothfield N Am J Med; 1988 Oct; 85(4A):53-6. PubMed ID: 3177431 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial. Lima GL; Paupitz J; Aikawa NE; Takayama L; Bonfa E; Pereira RM Arthritis Care Res (Hoboken); 2016 Jan; 68(1):91-8. PubMed ID: 25988278 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of antimalarials in systemic lupus erythematosus. Esdaile JM Lupus; 1993 Feb; 2 Suppl 1():S3-8. PubMed ID: 8485568 [TBL] [Abstract][Full Text] [Related]
17. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE; Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866 [TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. van Vollenhoven RF; Park JL; Genovese MC; West JP; McGuire JL Lupus; 1999; 8(3):181-7. PubMed ID: 10342710 [TBL] [Abstract][Full Text] [Related]
19. Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Kalunian KC; Urowitz MB; Isenberg D; Merrill JT; Petri M; Furie RA; Morgan-Cox MA; Taha R; Watts S; Silk M; Linnik MD Rheumatology (Oxford); 2018 Jan; 57(1):125-133. PubMed ID: 29045736 [TBL] [Abstract][Full Text] [Related]
20. Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Fortin PR; Abrahamowicz M; Ferland D; Lacaille D; Smith CD; Zummer M; Arthritis Rheum; 2008 Dec; 59(12):1796-804. PubMed ID: 19035431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]